Stock Analysis·← Pickers

IINNW

Inspira Technologies Oxy B.H.N. Ltd.

Inspira Technologies Oxy B.H.N. Ltd. (IINNW) is currently in a downtrend, trading below both the 50-day and 200-day moving averages. RSI is at 44.9, with 0/3 trend checks passing.

Price
$0.14
2026-07-16
Trend score
0/3
Downtrend
RSI (14)
44.9
Neutral
Price above MA50Price above MA200MA50 above MA200
Change stock
Search another ticker to view its stock analysis page.
Chart View

IINNW with MA50 and MA200

0.650.500.350.200.0507/0209/2612/2203/1906/15
IINNW2025-07-022026-06-15
PriceMA50MA200
Technical Indicators

Key levels & signals

MA50
$0.15-10.34% vs price
MA200
$0.24-45.95% vs price
RSI (14)
44.9Neutral zone
MACD Signal
BearishMomentum below signal
Macro Support
Not identifiedNo repeated weekly support zone found
Support Quality
Volume data unavailable
Chart Summary
Trend summary for IINNW

Inspira Technologies Oxy B.H.N. Ltd. (IINNW) currently looks weaker on the chart and is not showing much trend strength. The latest available price is $0.14, and 0 of 3 core trend checks are currently passing. Price is trading below the 50-day moving average by 10.3% and below the 200-day moving average by 46.0%.

Momentum and stretch context

IINNW currently has an RSI reading of 44.9, which leans a little softer than neutral. That does not automatically make the chart bearish, but it does suggest momentum is not especially strong right now.

What traders may watch next

For traders reviewing IINNW next, the main question is whether weakness is starting to stabilise or whether the chart still looks vulnerable to further downside. Some traders may watch for bounce attempts, but others will want to see stronger proof that the trend is improving before treating the stock as a cleaner setup.

Company profile

About Inspira Technologies Oxy B.H.N. Ltd.

Inspira Technologies Oxy B.H.N. Ltd. is a specialty medical device company dedicated to developing, manufacturing, and marketing innovative respiratory support technologies. Their core mission is to offer a non-invasive treatment alternative to traditional mechanical ventilation for individuals experiencing respiratory failure. The company's flagship product is the Augmented Respiration Technology (ART) system. This respiratory assistance device features a portable, minimally invasive dual-lumen cannula, which is inserted into the jugular vein. The ART system works by directly oxygenating blood outside the body (extracorporeal oxygenation), effectively elevating and stabilizing declining oxygen saturation levels. Originally incorporated in 2018 as Insense Medical Ltd., the company changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020 and is based in Ra'annana, Israel.

Sector
Healthcare
Industry
Medical - Devices
CEO
Dagi Shahar Ben-Noon
Employees
37
Market cap
$3.4M
Beta
2.16
52-week range
$0.00 – $0.80
Dividend
No
Exchange
NASDAQ
Country
IL
IPO date
14 Jul 2021
ISIN
IL0011761710
CUSIP
M53637118
Company profile data from Financial Modeling Prep. IINNW listed on NASDAQ.
Share dilution

IINNW shares outstanding over time

Tracking total shares outstanding is one way to spot dilution — a rising line means the company has issued more shares (stock-based compensation, secondary offerings, convertible debt), which spreads the same earnings and ownership across more shares. A falling line usually reflects buybacks.

Sept 2021Dec 2023
Shares outstanding (latest)
222.8M
Since Sept 2021
+2758.1%
Trend
More shares outstanding
Historical shares-outstanding data from Financial Modeling Prep. IINNW10 data points from Sept 2021 to Dec 2023.
Learn More

Learn the indicators behind this page

Explore More

More stock opportunities

FAQ

Common questions about IINNW

Is this page a buy or sell recommendation?

No. This page is designed to help you review chart structure, momentum and technical context more quickly, but it is not personal financial advice.

Why can a stock look bullish and overbought at the same time?

Strong trending stocks can still become stretched in the short term. That is why trend traders and dip buyers can read the same chart differently.

What should I do next after reading this page?

Open the full dashboard, review the chart in more detail, compare indicators, and decide whether the setup still makes sense within your own process.